Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Senior Strategic Marketing Manager
About the author:
Betsy’s entire marketing career has exclusively focused on the STEM market, with a distinct emphasis on Pharma. During her tenure with Elsevier’s Corporate R&D group, she has managed market segmentation for the pharma and life sciences industry, and launched and manages The Hive, a partnership with a select group of biotech and pharmaceutical start-ups focused on early stage innovation in drug discovery and development. The program promotes collaboration and inspiration across the Pharma & Life Sciences industry. Prior to launching her marketing career, Betsy worked as a management consultant focused on strategy implementation. She holds an MBA from the University of Michigan’s Ross School of Business and a BA from Barnard College of Columbia University.
Posts by Betsy Davis
Posted on February 14th, 2018 in The Hive
In 2017, Elsevier introduced a new program called The Hive, an innovation initiative for biotech and pharmaceutical start-ups committed to promoting collaboration and inspiration across the Pharma & Life Sciences industry.
Posted on January 8th, 2018 in Pharma R&D
In the 21st century, we are facing a number of enormous global challenges. Simply producing enough food and clean water to nourish the planet’s growing population is one of the biggest difficulties. Meanwhile, we must also deal with the ravages of climate change and take on medical problems like antibiotic resistance. Continue reading “Solving Global Research Challenges with Artificial Intelligence” »
Posted on December 22nd, 2017 in Pharma R&D
Our genetic make-up, where we live and how we live, are all important factors to consider when we are dealing with disease. For a very long time, medicine has mostly been designed to treat the sickness without much thought to the individual who has it. Continue reading “Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle” »
Posted on December 11th, 2017 in Pharma R&D
This year, four companies working in early-stage drug development were able to power their efforts with an array of Elsevier tools by participating in The Hive. Now, more promising pharma and biotech start-ups are in the process of entering into The Hive Continue reading “As The Hive Evolves, More Companies Prepare to Join the Program” »